These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. SARS-CoV-2 Incubation Period during Omicron BA.5-Dominant Period, Japan (Response). Ogata T; Tanaka H Emerg Infect Dis; 2024 Jan; 30(1):207. PubMed ID: 38146992 [No Abstract] [Full Text] [Related]
3. SARS-CoV-2 Incubation Period during the Omicron BA.5-Dominant Period in Japan. Ogata T; Tanaka H Emerg Infect Dis; 2023 Mar; 29(3):595-598. PubMed ID: 36787734 [TBL] [Abstract][Full Text] [Related]
4. Serial Intervals and Incubation Periods of SARS-CoV-2 Omicron and Delta Variants, Singapore. Zeng K; Santhya S; Soong A; Malhotra N; Pushparajah D; Thoon KC; Yeo B; Ho ZJM; Cheng MCI Emerg Infect Dis; 2023 Apr; 29(4):814-817. PubMed ID: 36878009 [TBL] [Abstract][Full Text] [Related]
5. Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study). Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Kuramochi J; Ihara G; Chubachi K; Yanagisawa N; Nagura Y; Kato Y; Ueda A; Numata A; Kato H; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Smith C; Hibberd M; Ariyoshi K; Suzuki M Clin Infect Dis; 2023 Feb; 76(3):e108-e115. PubMed ID: 35918782 [TBL] [Abstract][Full Text] [Related]
6. Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain. Del Águila-Mejía J; Wallmann R; Calvo-Montes J; Rodríguez-Lozano J; Valle-Madrazo T; Aginagalde-Llorente A Emerg Infect Dis; 2022 Jun; 28(6):1224-1228. PubMed ID: 35393009 [TBL] [Abstract][Full Text] [Related]
10. Reinfections with Different SARS-CoV-2 Omicron Subvariants, France. Nguyen NN; Houhamdi L; Delorme L; Colson P; Gautret P Emerg Infect Dis; 2022 Nov; 28(11):2341-2343. PubMed ID: 36150518 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of and Risk Factors for Post-COVID-19 Condition during Omicron BA.5-Dominant Wave, Japan. Iba A; Hosozawa M; Hori M; Muto Y; Muraki I; Masuda R; Tamiya N; Iso H Emerg Infect Dis; 2024 Jul; 30(7):1380-1389. PubMed ID: 38916571 [TBL] [Abstract][Full Text] [Related]
12. Shorter Incubation Period among COVID-19 Cases with the BA.1 Omicron Variant. Tanaka H; Ogata T; Shibata T; Nagai H; Takahashi Y; Kinoshita M; Matsubayashi K; Hattori S; Taniguchi C Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627870 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Variants and Age-Dependent Infection Rates among Household and Nonhousehold Contacts. Miyahara R; Tamura K; Kato T; Nakazaki M; Otani K; Ko YK; Kamigaki T; Arima Y; Tani H; Oishi K; Suzuki M Emerg Infect Dis; 2023 Aug; 29(8):1648-1650. PubMed ID: 37343546 [TBL] [Abstract][Full Text] [Related]
14. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees. Takahashi K; Ishikane M; Ujiie M; Iwamoto N; Okumura N; Sato T; Nagashima M; Moriya A; Suzuki M; Hojo M; Kanno T; Saito S; Miyamoto S; Ainai A; Tobiume M; Arashiro T; Fujimoto T; Saito T; Yamato M; Suzuki T; Ohmagari N Emerg Infect Dis; 2022 May; 28(5):998-1001. PubMed ID: 35290176 [TBL] [Abstract][Full Text] [Related]